Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-29

FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a citalopram hydrobromide product manufactured by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM HYDROBROMIDE)